>
QRxPharma logo

QRX - QRxPharma Share Price

A$0.028 0.0  0.0%

Last Trade - 22/05/15

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £2.61k
Position in Universe th / 1911
Bullish
Bearish
Unlock QRX Revenue
Momentum
Relative Strength (%)
1m +56.4%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2012 2013 2014 2015 2016 2017 2018E 2019E CAGR / Avg
1.92 4.07 0.67 0.009 0.016 0.008 -66.5%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 31 December 2017, QRxPharmaLtd. revenues decreased 67% to A$2K. Net loss decreased 18%to A$191K. Revenues reflect a decrease in demand for theCompany's products and services due to unfavorable marketconditions. Lower net loss reflects Employee benefitexpenses decrease from A$38K (expense) to A$0K,Restructuring expense decrease from A$6K (expense) to A$0K.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

QRX Revenue Unlock QRX Revenue

Net Income

QRX Net Income Unlock QRX Revenue

Normalised EPS

QRX Normalised EPS Unlock QRX Revenue

PE Ratio Range

QRX PE Ratio Range Unlock QRX Revenue

Dividend Yield Range

QRX Dividend Yield Range Unlock QRX Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
QRX EPS Forecasts Unlock QRX Revenue
Profile Summary

QRxPharma Limited is a specialty pharmaceutical company. The Company is focused on the development and commercialization of biopharmaceutical products. The Company's operating segment is that of the research and development of biopharmaceutical products for commercial sale. The Company focuses on the development of new treatments for pain management and abuse prevention products. The Company's Dual Opioid platform technology is a fixed-ratio combination of morphine and oxycodone, which provides analgesia and can manage opioid-related side effects. It has approximately four pain management product formulations in late and early-stage clinical development, including Moxduo IR, an immediate release oral capsule for acute pain; an abuse deterrent formulation of Moxduo IR; Moxduo CR, a controlled release oral tablet (with abuse deterrent and tamper resistant technologies) for chronic pain, and Moxduo IV, an intravenous formulation for moderate to severe hospital-based pain.

Directors
Last Annual June 30th, 2017
Last Interim December 31st, 2017
Incorporated September 19, 2002
Public Since May 28, 2007
No. of Shareholders: 2,259
No. of Employees: n/a
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange Australian Stock Exchange - SEATS
Shares in Issue 164,190,969
Free Float (0.0%)
Eligible for
ISAs
SIPPs
QRX Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for QRX
Upcoming Events for QRX
Frequently Asked Questions for QRxPharma
What is the QRxPharma share price?

As of 22/05/15, shares in QRxPharma are trading at A$0.028, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the QRxPharma share price performed this year?

Shares in QRxPharma are currently trading at A$0.028 and the price has moved by -65.43% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the QRxPharma price has moved by -74.13% over the past year.

What are the analyst and broker recommendations for QRxPharma?

Of the analysts with advisory recommendations for QRxPharma, there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for QRxPharma is Not available. You can view the full broker recommendation list by unlocking its StockReport.

When will QRxPharma next release its financial results?

QRxPharma is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2018-12-31
What is the QRxPharma dividend yield?

QRxPharma does not currently pay a dividend.

Does QRxPharma pay a dividend?

QRxPharma does not currently pay a dividend.

When does QRxPharma next pay dividends?

QRxPharma does not currently pay a dividend.

How do I buy QRxPharma shares?

To buy shares in QRxPharma you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of QRxPharma?

Shares in QRxPharma are currently trading at A$0.028, giving the company a market capitalisation of £n/a.

Where are QRxPharma shares listed? Where are QRxPharma shares listed?

Here are the trading details for QRxPharma:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: QRX
What kind of share is QRxPharma?

We were not able to load our ranking data for QRxPharma

Is there a QRxPharma share price forecast 2021?

We were not able to load any forecast data for QRxPharma.

How can I tell whether the QRxPharma share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like QRxPharma. Over the past six months, the relative strength of its shares against the market has been 61.65%. At the current price of A$0.028, shares in QRxPharma are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the QRxPharma PE Ratio?

We were not able to find PE ratio data for QRxPharma.

Who are the key directors of QRxPharma?

We were unable to find the directors for QRxPharma.

Who are the major shareholders of QRxPharma?

Here are the top five shareholders of QRxPharma based on the size of their shareholding:

Similar to QRX
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.